Michael Baldwin

964 total citations
40 papers, 699 citations indexed

About

Michael Baldwin is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Hematology. According to data from OpenAlex, Michael Baldwin has authored 40 papers receiving a total of 699 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pulmonary and Respiratory Medicine, 14 papers in Physiology and 6 papers in Hematology. Recurrent topics in Michael Baldwin's work include Chronic Obstructive Pulmonary Disease (COPD) Research (17 papers), Respiratory and Cough-Related Research (10 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (9 papers). Michael Baldwin is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (17 papers), Respiratory and Cough-Related Research (10 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (9 papers). Michael Baldwin collaborates with scholars based in United States, Germany and United Kingdom. Michael Baldwin's co-authors include Paul M. Ness, David Price, Timothy W. Smith, Alan J. Christensen, Marc Miravitlles, Rupert Jones, Kevin Gruffydd‐Jones, Rebecca Stewart, Guy Brusselle and Dorothy L. Keininger and has published in prestigious journals such as American Journal of Obstetrics and Gynecology, European Respiratory Journal and Psychophysiology.

In The Last Decade

Michael Baldwin

39 papers receiving 657 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Baldwin United States 15 428 316 110 44 42 40 699
Sohaib Aleem United States 9 29 0.1× 274 0.9× 40 0.4× 26 0.6× 4 0.1× 11 508
Stephen M. Amrock United States 12 41 0.1× 352 1.1× 13 0.1× 25 0.6× 2 0.0× 17 605
Sofia Georgopoulou United Kingdom 12 112 0.3× 82 0.3× 87 0.8× 15 0.3× 25 436
Lampros Fotis Greece 10 51 0.1× 30 0.1× 18 0.2× 10 0.2× 8 0.2× 23 494
Ou Chen China 14 144 0.3× 108 0.3× 15 0.1× 27 0.6× 1 0.0× 41 508
Asya Al‐Riyami Oman 11 50 0.1× 77 0.2× 75 0.7× 85 1.9× 2 0.0× 27 464
Grettel Castro United States 11 39 0.1× 63 0.2× 10 0.1× 19 0.4× 6 0.1× 54 389
Richard W. Seidel United States 9 67 0.2× 70 0.2× 30 0.3× 39 0.9× 16 413
Marci Clark United States 11 51 0.1× 55 0.2× 26 0.2× 57 1.3× 1 0.0× 21 495
Cara Hanby United States 7 34 0.1× 113 0.4× 108 1.0× 391 8.9× 14 660

Countries citing papers authored by Michael Baldwin

Since Specialization
Citations

This map shows the geographic impact of Michael Baldwin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Baldwin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Baldwin more than expected).

Fields of papers citing papers by Michael Baldwin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Baldwin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Baldwin. The network helps show where Michael Baldwin may publish in the future.

Co-authorship network of co-authors of Michael Baldwin

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Baldwin. A scholar is included among the top collaborators of Michael Baldwin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Baldwin. Michael Baldwin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wijsenbeek, Marlies, Jeffrey J. Swigris, Yoshikazu Inoue, et al.. (2023). Effects of nintedanib on symptoms in patients with progressive pulmonary fibrosis. European Respiratory Journal. 63(2). 2300752–2300752. 27 indexed citations
2.
3.
Wijsenbeek, Marlies, María Molina‐Molina, Olivier Chassany, et al.. (2022). Developing a conceptual model of symptoms and impacts in progressive fibrosing interstitial lung disease to evaluate patient-reported outcome measures. ERJ Open Research. 8(2). 681–2021. 10 indexed citations
4.
Olson, Amy L., N Hartmann, Padmaja Patnaik, et al.. (2022). Healthcare Resource Utilization and Related Costs in Chronic Fibrosing Interstitial Lung Diseases with a Progressive Phenotype: A US Claims Database Analysis. Advances in Therapy. 39(4). 1794–1809. 7 indexed citations
5.
6.
7.
Olson, Amy L., N Hartmann, Padmaja Patnaik, et al.. (2020). PRS25 HEALTHCARE RESOURCE UTILIZATION AND RELATED COSTS IN PROGRESSIVE FIBROSING INTERSTITIAL LUNG DISEASES (ILDS). Value in Health. 23. S353–S353. 2 indexed citations
8.
9.
Hoogendoorn, Martine, et al.. (2019). <p>Long-term cost-effectiveness of the fixed-dose combination of tiotropium plus olodaterol based on the DYNAGITO trial results</p>. International Journal of COPD. Volume 14. 447–456. 6 indexed citations
10.
11.
Gruffydd‐Jones, Kevin, Guy Brusselle, Rupert Jones, et al.. (2016). Changes in initial COPD treatment choice over time and factors influencing prescribing decisions in UK primary care: a real-world study. npj Primary Care Respiratory Medicine. 26(1). 16002–16002. 33 indexed citations
12.
Borgström, Fredrik, et al.. (2015). Cost-Effectiveness Of Tiotropium Vs Glycopyrronium In Moderate To Very Severe Copd In Spain. Value in Health. 18(7). A501–A501. 1 indexed citations
13.
Price, David, Guy Brusselle, Kevin Gruffydd‐Jones, et al.. (2015). The inevitable drift to triple therapy in COPD: an analysis of prescribing pathways in the UK. International Journal of COPD. 10. 2207–2207. 128 indexed citations
14.
Price, David, Rupert Jones, Kevin Gruffydd‐Jones, et al.. (2014). Real-world prescribing patterns among newly diagnosed COPD patients receiving ICS: An analysis of UK patient dataset. European Respiratory Journal. 44(Suppl 58). P2422–P2422. 4 indexed citations
15.
16.
Price, David, Rupert Jones, Kevin Gruffydd‐Jones, et al.. (2014). Analyzing the pathway to triple therapy in COPD patients: A retrospective database analysis. European Respiratory Journal. 44(Suppl 58). P2411–P2411. 3 indexed citations
17.
Cope, Shannon, James F. Donohue, Jeroen P. Jansen, et al.. (2013). Comparative efficacy of long-acting bronchodilators for COPD - a network meta-analysis. Respiratory Research. 14(1). 100–100. 51 indexed citations
18.
Kraemer, Matthias, Alexandra G. Ellis, Michael Baldwin, et al.. (2012). PRS5 Dual Bronchodilation With Indacaterol and Tiotropium in Combination Versus Triple Therapy, Fixed-Dose Combinations, and Monotherapy in COPD – a Network Meta-Analysis of FEV1. Value in Health. 15(7). A560–A560. 3 indexed citations
19.
Smith, Timothy W., Michael Baldwin, & Alan J. Christensen. (1990). Interpersonal Influence as Active Coping: Effects of Task Difficulty on Cardiovascular Reactivity. Psychophysiology. 27(4). 429–437. 70 indexed citations
20.
Baldwin, Michael, et al.. (1988). Alloimmunization to D antigen and HLA in D‐negative immunosuppressed oncology patients. Transfusion. 28(4). 330–333. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sohaib Aleem Breakdown of academic impact, for papers by Stephen M. Amrock Breakdown of academic impact, for papers by Sofia Georgopoulou Breakdown of academic impact, for papers by Lampros Fotis Breakdown of academic impact, for papers by Ou Chen Breakdown of academic impact, for papers by Asya Al‐Riyami Breakdown of academic impact, for papers by Grettel Castro Breakdown of academic impact, for papers by Richard W. Seidel Breakdown of academic impact, for papers by Marci Clark Breakdown of academic impact, for papers by Cara Hanby
Rankless by CCL
2026